These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9009321)
1. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Palfreyman RW; Watson ML; Eden C; Smith AW Infect Immun; 1997 Feb; 65(2):617-22. PubMed ID: 9009321 [TBL] [Abstract][Full Text] [Related]
2. Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: signaling through CD14 and mitogen-activated protein kinase. Reddi K; Phagoo SB; Anderson KD; Warburton D Pediatr Res; 2003 Sep; 54(3):297-305. PubMed ID: 12761358 [TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium. Fink J; Steer JH; Joyce DA; McWilliam AS; Stewart GA FEMS Immunol Med Microbiol; 2003 Oct; 38(3):273-82. PubMed ID: 14522463 [TBL] [Abstract][Full Text] [Related]
4. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Kaza SK; McClean S; Callaghan M Int J Med Microbiol; 2011 Jan; 301(1):26-33. PubMed ID: 20829108 [TBL] [Abstract][Full Text] [Related]
5. Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth. Mariappan V; Vellasamy KM; Hashim OH; Vadivelu J PLoS One; 2011; 6(10):e26518. PubMed ID: 22046299 [TBL] [Abstract][Full Text] [Related]
6. Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B. Shimomura H; Matsuura M; Saito S; Hirai Y; Isshiki Y; Kawahara K Infect Immun; 2003 Sep; 71(9):5225-30. PubMed ID: 12933868 [TBL] [Abstract][Full Text] [Related]
7. IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa B and activator protein-2. Smith RS; Fedyk ER; Springer TA; Mukaida N; Iglewski BH; Phipps RP J Immunol; 2001 Jul; 167(1):366-74. PubMed ID: 11418672 [TBL] [Abstract][Full Text] [Related]
8. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia. Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780 [TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426 [TBL] [Abstract][Full Text] [Related]
11. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977 [TBL] [Abstract][Full Text] [Related]
12. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Zughaier SM; Ryley HC; Jackson SK Infect Immun; 1999 Feb; 67(2):908-13. PubMed ID: 9916107 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Zughaier SM; Ryley HC; Jackson SK Infect Immun; 1999 Mar; 67(3):1505-7. PubMed ID: 10024601 [TBL] [Abstract][Full Text] [Related]
14. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887 [TBL] [Abstract][Full Text] [Related]
15. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. Butler SL; Nelson JW; Poxton IR; Govan JR FEMS Immunol Med Microbiol; 1994 May; 8(4):285-92. PubMed ID: 7520313 [TBL] [Abstract][Full Text] [Related]
16. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291 [TBL] [Abstract][Full Text] [Related]
17. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Hughes JE; Stewart J; Barclay GR; Govan JR Infect Immun; 1997 Oct; 65(10):4281-7. PubMed ID: 9317038 [TBL] [Abstract][Full Text] [Related]